CME Corner

Active Programs

The Value of Biosimilars in the Treatment of Inflammatory Bowel Disease

A number of biosimilars have been approved in recent years, offering additional treatment options for patients with IBD. Given the novelty of biosimilars in the U.S., it’s not surprising that clinicians have questions. In this activity, faculty will define biosimilars, examine how they’re studied and regulated, and discuss their current and potential role in IBD management, including how they migh ...

  • Video Roundtable Video Roundtable

Optimizing Immunization in IBD: A Quality Improvement Curriculum, Part 1

This activity simulates a quality improvement initiative to illuminate best practices in the immunization of patients with IBD. ...

  • Mobile + Online on RealCME Mobile + Online on RealCME

Metastatic Colorectal Cancer: Applying Evidence-based Recommendations for Evaluation and Management

Colorectal cancer is the third most common cancer in men and women. Current evidence-based guidelines recommend that all metastatic colorectal tumors be tested for RAS mutations (both KRAS and NRAS) and BRAF mutations, as the presence of such mutations has implications for treatment. Clinical practice is variable, however, and many patients do not receive guideline-based care. This activity will e ...

  • Online Presentation
  • ANCC

Expired Programs

Effective Strategies for Improving Process of Care Measures for Patients with IBD: Key Findings from a Community-Based QI Pilot

This activity will examine key findings from a quality improvement pilot designed to learn how IBD nurses in the community can proactively improve the care of patients with IBD. ...

  • Video Roundtable Video Roundtable
  • ANCC

Identifying and Managing Patients with IBD at Risk for Progressive Disease

Treatment strategies for IBD vary depending on disease type, severity, and patient risk profile. This activity will examine severity and risk assessment, guideline recommended treatment, and patient communication strategies. ...

  • Online Presentation Online Presentation

Improving Outcomes in Advanced Gastric Cancer: The Latest Updates in Treatment Strategies and Clinical Research

An estimated 26,370 Americans will be diagnosed with gastric cancer in 2016. Most patients with gastric cancer present with advanced or metastatic disease, for which the prognosis is poor. The 5-year survival rate of patients with all stages of gastric cancer in the United States is approximately 29% and drops into the single digits for patients with stage III or IV disease. However, recent advanc ...

  • Mobile + Online on Univadis Mobile + Online on Univadis

Primary Care Perspectives: Recognizing and Managing Opioid-Induced Constipation

Constipation is a common adverse effect resulting from opioid medications: an estimated 40% of patients receiving opioids to manage noncancer pain experience opioid-induced constipation (OIC). Unlike other adverse effects of opioids, such as nausea, the severity of OIC rarely diminishes over time and is often dose limiting. As a result, OIC can have a significant negative impact on activities of d ...

  • Mobile + Online on Univadis
Main Menu